News & Opinion

New partnership to advance public health and life science research collaboration in West Africa

13 February 2025

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Abstract submissions open for International Pandemic Sciences Conference 2025

6 February 2025

Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.

Study provides new insights into mpox clinical outcomes and transmission

16 January 2025

Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.

Pig research paves way for human respiratory vaccine development

9 January 2025

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

A group of attendees listening to the conference talks.

Registration now open for International Pandemic Sciences Conference 2025

7 January 2025

Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.

Optimising testing for disease surveillance with machine learning

19 December 2024

A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.

PSI’s Md Zakiul Hassan recognised as 2024 ISID Emerging Leader

10 December 2024

The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.

Nipah Virus Research Day showcases cross-disciplinary advances

6 December 2024

Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.

WHO’s Dr Chikwe Ihekweazu shares public health leadership insights at PSI seminar

5 December 2024

Launching his new book, the WHO Assistant Director-General and former Director General of the Nigeria Centre for Disease Control (NCDC) shared his experience as a frontline policymaker leading a burgeoning national public health institute in the face of COVID-19.

Partnership with Universiti Malaysia Sabah to advance understanding of emerging viruses

18 November 2024

PSI has signed a Memorandum of Understanding with Universiti Malaysia Sabah (UMS), to advance a shared understanding of the risks of emerging viruses in regions rich in biodiversity.

University of Oxford unveils new vaccine development partnership

15 November 2024

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu

11 November 2024

Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.

Reconstructing a lifetime of flu infections to understand long-term trends

8 November 2024

Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.

£5.5m funding boost for health protection research on emerging and zoonotic infections

7 November 2024

University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.

Professor David Aanensen honoured with 2025 Translational Microbiology Prize

7 November 2024

The award recognises the PSI Investigator’s work in the areas of translational microbiology and genomic epidemiology.

Moh Family Foundation visit highlights vital support for pandemic preparedness research

24 October 2024

The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation’s generous support.

Large-scale study on Long Covid highlights urgent, global need for investment

22 October 2024

A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.

Search results (110)